About Rockland Immunochemicals
Rockland Immunochemicals is a company based in Philadelphia (United States) founded in 1962. It operates as a Professional Services and Direct-to-Consumer (D2C). Rockland Immunochemicals has completed 1 acquisition, including antibodies-online. Rockland Immunochemicals offers products and services including Primary Antibodies, Custom Antibody Production, and Protein & Antibody Characterization. Rockland Immunochemicals operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Rockland Immunochemicals, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$714.07 K (USD), Grant
Sep 01, 2014
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rockland Immunochemicals
Rockland Immunochemicals offers a comprehensive portfolio of products and services, including Primary Antibodies, Custom Antibody Production, and Protein & Antibody Characterization.
Antibodies are provided for research and diagnostics purposes.
Custom antibodies are developed for specific research needs.
Characterization services are offered for proteins and antibodies.
People of Rockland Immunochemicals
Unlock access to complete
Funding Insights of Rockland Immunochemicals
Investors in Rockland Immunochemicals
Rockland Immunochemicals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Rockland Immunochemicals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rockland Immunochemicals
Rockland Immunochemicals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include antibodies-online.
Investment portfolio details for Rockland Immunochemicals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Online store for selling antibody kits
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Rockland Immunochemicals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Rockland Immunochemicals
Detailed financials for Rockland Immunochemicals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rockland Immunochemicals Comparisons
Peer comparison for Rockland Immunochemicals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rockland Immunochemicals
Rockland Immunochemicals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
CDMO offering drug and biologics development services
|
|
| Locked | Locked | Locked |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| Locked | Locked | Locked |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| Locked | Locked | Locked |
Drug research, development, testing, and consulting services are provided.
|
|
| Locked | Locked | Locked |
Protein therapeutics are developed and manufactured by WuXi Biologics.
|
Detailed competitors of Rockland Immunochemicals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rockland Immunochemicals
Complete news archive for Rockland Immunochemicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rockland Immunochemicals
Rockland Immunochemicals was founded in 1962 and raised its 1st funding round 47 years after it was founded.
Rockland Immunochemicals is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Rockland Immunochemicals is involved in the development and supply of high-quality antibodies, reagents, and custom services for research and diagnostics. The company serves industries such as AgBio, Biopharma, Diagnostics, and Emerging Therapeutics. Solutions include primary and secondary antibodies, custom antibody production, protein characterization, and assay development. Expertise is applied to advance life sciences through innovative products and technical support, fostering scientific discovery and development across multiple sectors.
Rockland Immunochemicals offers Primary Antibodies, Custom Antibody Production, and Protein & Antibody Characterization.
Rockland Immunochemicals has made 1 acquisition, including antibodies-online.
Rockland Immunochemicals has 1 investor. Key investors include HHS.